J&J joins legal fight against Medicare drug price negotiation
U.S. pharmaceutical company Johnson & Johnson (J&J) announced Tuesday it is suing the Department of Health and Human Services (HHS) over Medicare Drug Price Negotiation Program, becoming the latest of several organizations challenging the provision established by the Inflation Reduction Act. J&J joins fellow pharmaceutical companies Merck & Co., Bristol Myers Squibb as well as…